Member Info for panda1

You have misunderstood the RNS.
The £100k invested is for 10% of the Lithium project not the whole company!
It demonstrates that significant value has been added recently by the acquisition of the licences with some very big potential upside.

It was increased to $70 at the end of January

The directors probably can't buy shares due to corporate activity going on in the background - Malcy said he is sure something is going on

It has been stated in the accounts and Brian has mentioned it before when asked

Looking forward to the share buyback programme which should give the share price a big boost.
The company may decide to start buying shares sooner than originally planned due to the success of recent well results

Only 220bp/d are hedged

Also worth bearing in mind that the £193 million Victory NPV10 assumes a gas price of 50p/therm and it is currently over 3 times that level and has been as high as 450p in recent weeks

Surely we should see a big re-rate today.
Best news for the company I've seen

Excellent result announced today with larger amount of pay than expected

I meant £28m market cap.

Pasafino are earning 49% of the Dugbe project by taking it to DFS stage. HUM retain 51% of Dugbe which in theory it is worth a bit more than Pasafino's market cap of £38m.

Where are you getting the £14m valuation from?

TW calling for these shares to be suspended.
No matter how 'cheaply' people buy the stock if it goes belly up all shareholders lose 100% of their investment

These big trades could be Atlas's worked sell orders being printed

"The researchers are now working with pharmaceutical companies to explore the development of, or the repurposing of existing treatments, which target the TLR7 gene. And they hope that targeting this gene could also help patients with related conditions.

Carola adds: “There are other systemic autoimmune diseases, like rheumatoid arthritis and dermatomyositis, which fit within the same broad family as lupus. TLR7 may also play a role in these conditions.”

Carola has started a new laboratory at the Francis Crick Institute to further understand the disease-causing mechanisms that occur downstream of key mutations like the one found on the TLR7 gene."

It's potentially very good news for people with Lupus but bad news for IMM as it increases the likelihood of a more effective treatment for Lupus

Are you sticking with your 3.6p target nookie?

Lupus gene discovery brings cure hope to Britain’s 50,000 sufferers
Scientists found that a single mutation in the TLR7 gene drives the condition, and are now searching for a drug that could fix the defect.
Scientists at London’s Francis Crick Institute found that a single mutation in the TLR7 gene can drive the condition, and have started working with pharmaceutical companies to find drugs that could fix the defect.

I can't see there being many buyers out there as everyone knows Atlas are on the other side of the trade and have virtually an unlimited amount of shares to sell

Atlas will be able to convert at 0.3p per share or below now